Security key
64125C109
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)
CUSIP: 64125C109
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 98,821,219
- Total 13F value
- $12,420,453,326
- Share change
- +3,693,430
- Put/Call ratio
- 74%
- SEC-reported price per share
- $125.69
- Number of holders
- 578
- Value change
- +$494,184,481
- Number of buys
- 295
- Number of sells
- 286
- Shares outstanding
- 100,534,245
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
578
Top holders
10
NBIX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
NEUROCRINE BIOSCIENCES INC SEC filings
NEUROCRINE BIOSCIENCES INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 64125C109
Recent filing periods:
Ownership snapshot
Top reported holders of NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
13D/G
Lead comparable stake: 12%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
12%
DODGE & COX
5.6%
STATE STREET CORP
4.8%
VANGUARD GROUP INC
9.9%
JPMORGAN CHASE & CO
2.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
12%
from 13D/G
|
$1,623,872,774
14,682,394 shares
|
— | 31 Mar 2025 |
| DODGE & COX |
13F
13D/G
Company
|
5.6%
from 13D/G
|
$612,129,414
5,534,624 shares
|
— | 31 Mar 2025 |
| STATE STREET CORP |
13F
13D/G
Company · STATE STREET CORPORATION
|
4.8%
from 13D/G
|
$537,750,030
4,862,116 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
9.9%
|
$1,099,572,701
9,941,887 shares
|
— | 31 Mar 2025 |
| JPMORGAN CHASE & CO |
13F
Company
|
2.7%
|
$295,412,423
2,670,998 shares
|
— | 31 Mar 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
2.5%
|
$276,798,288
2,502,697 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
578
Shares
98,821,219
Rows available
578
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
579
Q2 2025 holders
578
Holder diff
-1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend